105 related articles for article (PubMed ID: 19224893)
1. Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?
Wang Z; Chen C; Finger SN; Kwajah S; Jung M; Schwarz H; Swanson N; Lareu FF; Raghunath M
Eur Respir J; 2009 Jul; 34(1):145-55. PubMed ID: 19224893
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid attenuates epidural fibrosis via inhibiting myofibroblast differentiation and increasing fibroblast apoptosis.
Yang JS; Liu P; Liu JJ; Chu L; Li J; Chen C; Yan L; Liu TJ; Chen H; Hao DJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5726-5733. PubMed ID: 32495908
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes.
Shi ZJ; Ouyang DY; Zhu JS; Xu LH; He XH
Int Immunopharmacol; 2012 Apr; 12(4):580-7. PubMed ID: 22369900
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.
Ramos C; Montaño M; García-Alvarez J; Ruiz V; Uhal BD; Selman M; Pardo A
Am J Respir Cell Mol Biol; 2001 May; 24(5):591-8. PubMed ID: 11350829
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
Nonaka M; Pawankar R; Fukumoto A; Yagi T
Clin Exp Allergy; 2008 May; 38(5):812-21. PubMed ID: 18355371
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of suberoylanilide hydroxamic acid (Vorinostat) in the treatment of canine corneal fibrosis.
Bosiack AP; Giuliano EA; Gupta R; Mohan RR
Vet Ophthalmol; 2012 Sep; 15(5):307-14. PubMed ID: 22212187
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
[TBL] [Abstract][Full Text] [Related]
11. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
12. Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).
Özel M; Baskol M; Akalın H; Baskol G
Cell Biochem Biophys; 2021 Jun; 79(2):349-357. PubMed ID: 33689126
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid (vorinostat): its role on equine corneal fibrosis and matrix metalloproteinase activity.
Donnelly KS; Giuliano EA; Sharm A; Mohan RR
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():61-8. PubMed ID: 25126665
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
15. Suberoylanilide hydroxamic acid attenuates paraquat-induced pulmonary fibrosis by preventing Smad7 from deacetylation in rats.
Rao SS; Zhang XY; Shi MJ; Xiao Y; Zhang YY; Wang YY; Zhang CZ; Shao SJ; Liu XM; Guo B
J Thorac Dis; 2016 Sep; 8(9):2485-2494. PubMed ID: 27747000
[TBL] [Abstract][Full Text] [Related]
16. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
Mizuno S; Matsumoto K; Li MY; Nakamura T
FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
